|
Send Inquiry
+919016820285Contact Us For Help
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Ruxolitinib Tablet
Product Details:
- Formulations Type Other Types
- Formulations Form Tablets
- Dosage Guidelines As Directed By Physician
- Volume 20 mg
- Storage Instructions Store in Cool
- Supply Ability : 1 Box Lac tablet/month
25 USD ($)
X
Price And Quantity
- As required by client. Box
- 25 USD ($)
Product Specifications
- As Directed By Physician
- Tablets
- 20 mg
- Store in Cool
- Other Types
Trade Information
- Hazira / Nhava Sheva
- Telegraphic Transfer (T/T), Cash Advance (CA)
- 1 Box Lac tablet/month
- 2 Week
- Yes
- If order is confirmed we will reimburse the sample cost
- Packing : 10X10 Tablets/Box Pack Insert/Leaflet : Yes
- WHO-GMP/ GMP/ COA/ As Required By Client
Product Description
Our company is counted among the topmost entities, engahed in exporting a wide stock of Ruxolitinib Tablet. It is indicated for the treatment of disease-related splenomegaly or symptoms. Highly recommended for adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis, Ruxolitinib Tablet is offered to clients in excellent packing at competitive price.
Key points:
- Indicated for the treatment of certain bone marrow disorders such as myelofibrosis and polycythemia vera
- It works by blocking your body from producing substances called growth factors
Ruxolitinib Tablet
- Product name: Ruxolitinib tablet 20mg
- Brand name: JAKAVI 20mg
Other Products in 'Pharmaceutical Drugs' category
Contact Details
- Reg. Office : Office No. U.G - 81, Diamond World, Tower-A, Near Prince Plaza, Mini Bazaar, Varachha Road, Surat - 395006, Gujarat, India
- Corp. office :
#803, Shubh Square,Patelwadi-3, Near Lal Darwaja,Surat - 395004 (Gujarat) India. -
Send Inquiry
- Phone :+918037303586
- Mr Viral Dhaduk (Director)
- Mobile :918037303586
Send Inquiry
Send SMS
Call Me Free
 |
SALVAVIDAS PHARMACEUTICAL PVT. LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Ltd. |